about
Exploiting tumor epigenetics to improve oncolytic virotherapyCancer genome landscapesThe association between global DNA methylation and telomere length in a longitudinal study of boilermakersStress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?Epigenetic modulators, modifiers and mediators in cancer aetiology and progressionCommon stemness regulators of embryonic and cancer stem cellsDedifferentiation and reprogramming: origins of cancer stem cellsGenomics, personalized medicine, and pediatricsBrain tumor stem cells: Molecular characteristics and their impact on therapyChromatin dynamics during cellular reprogrammingFractal dimension of chromatin: potential molecular diagnostic applications for cancer prognosisHistone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinomaBidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneityEpigenetics in Intestinal Epithelial Cell RenewalMetabolic control of cancer cell stemness: Lessons from iPS cellsChromatin regulation at the frontier of synthetic biologyPoly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancerRole of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer developmentFunctional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML)G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell CarcinomaThe Global Relationship between Chromatin Physical Topology, Fractal Structure, and Gene ExpressionIndividualized medicine from prewomb to tombGenome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.Inhibition of H3K9me2 Reduces Hair Cell Regeneration after Hair Cell Loss in the Zebrafish Lateral Line by Down-Regulating the Wnt and Fgf Signaling Pathways.Some Statistical Strategies for DAE-seq Data Analysis: Variable Selection and Modeling Dependencies among Observations.Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.Integrative methods for analyzing big data in precision medicine.Gender-specific DNA methylome analysis of a Han Chinese longevity populationEpigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer.JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.Molecular culprits generating brain tumor stem cellsRegulation of angiotensin II type 1 receptor expression in ovarian cancer: a potential role for BRCA1Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell linesCombined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.DMRforPairs: identifying differentially methylated regions between unique samples using array based methylation profilesDNA methylation dysregulations in rheumatic heart valve disease.RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma.SOX7: from a developmental regulator to an emerging tumor suppressor
P2860
Q21131237-9DE8C965-C683-4CFE-A346-CE26A12001CCQ22242276-0C9797E6-599F-4111-B861-8704B5CB432EQ23914496-6FB868F6-F39C-40BD-9F03-5337C8CA62DBQ26739748-CC494B74-8151-4608-AD1A-72918ACC719FQ26766149-1F8C5A8D-A40B-44D8-802E-2D953E463BF8Q26777882-9C1C2DB6-FFFC-4DCF-A82E-26DA11BEB52FQ26826876-55620321-9336-4304-B9DB-F42B55870C82Q26991570-B9662FA5-269B-4507-94C0-83A453B8E328Q27003138-627AABBD-CEE4-4285-93D2-53384693F8B6Q27003401-4B2B363E-47A3-47DF-AE66-92BDFD1EAC47Q27025883-F4195F2A-3A72-4AD0-BB9E-46B33D017220Q27025984-F75A220F-649F-4A5E-B4C4-9D096E61D4B7Q28066409-CD07FAC3-5A14-4FB3-9F60-752CD8343B2BQ28071369-EDF88918-B5C4-43A0-AA52-44F71DB18C58Q28081608-A714095A-BC1B-4122-9DCD-BA4D8CA2E246Q28083608-F78F8AE7-78B8-480A-AD78-B7751E983AFAQ28306291-9BC097AA-B385-4EA0-88AD-9DC6841AC46FQ28509811-BFD70AE6-6558-46C5-8810-E4DA7BA4063AQ28546856-92275C3B-2457-44EE-A441-8AB977D85FE8Q28548356-9509A818-8636-4B28-9B01-62D82F342FC5Q28818455-4C691194-60D4-4B86-A781-5BF882FE341FQ29525070-C1D03294-7698-4E30-B20A-D4BB75FA478DQ30252934-4EB832F3-950E-45DD-85A5-D08423D4C5F2Q30368024-748B8EF0-7460-4B1C-91D7-736EC8B09787Q30381443-E781FF80-77F7-4A22-BF1B-161B76515C54Q30788065-04109E31-0314-40A3-B8C3-20443399DDA9Q30851277-CCE7F36E-F36F-4C0D-9812-854689029DB3Q31032576-7B6FAA80-C199-41BC-900E-C8F0DC8C1790Q33562413-9CEB4EA0-E2BB-4E02-9209-565128CFD4C9Q33576891-4174B8A1-E6EC-4489-ACB0-54B74190389FQ33591745-BD247AB2-7C46-4B35-BE53-85582F669538Q33635399-1EA73F35-3EF5-4BD4-A60E-F13A0987CAF9Q33644360-B83F3DD1-36CE-4579-A7FC-E598D949908DQ33700563-DABEBFD1-F22B-4FA6-98BC-4D30AB03A5D6Q33702347-AE127DAB-D317-46C4-B5C9-735C17EFBD25Q33705644-9E6BFA04-FE7D-4B04-8C99-33FCBD33ACA1Q33712970-5FABA217-E008-4268-ACC6-3C5E8D9FFF36Q33808656-1C043A15-1A2C-4F74-B68C-FB073DA6B61DQ33850829-B950F7D9-3F3C-484A-A678-46AC3CDF69D2Q33937223-C9525812-3BAF-4186-A5E5-CA607616E175
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetic reprogramming in cancer.
@en
Epigenetic reprogramming in cancer.
@nl
type
label
Epigenetic reprogramming in cancer.
@en
Epigenetic reprogramming in cancer.
@nl
prefLabel
Epigenetic reprogramming in cancer.
@en
Epigenetic reprogramming in cancer.
@nl
P2093
P2860
P356
P1433
P1476
Epigenetic reprogramming in cancer.
@en
P2093
Bradley E Bernstein
Mario L Suvà
Nicolo Riggi
P2860
P304
P356
10.1126/SCIENCE.1230184
P407
P577
2013-03-01T00:00:00Z